MYLAN 5300 MYLAN 5300 (Nizatidine 300 mg)
Pill imprint MYLAN 5300 MYLAN 5300 has been identified as Nizatidine 300 mg.
Nizatidine is used in the treatment of duodenal ulcer; stomach ulcer; indigestion; erosive esophagitis; duodenal ulcer prophylaxis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN 5300 MYLAN 5300 (Nizatidine 300 mg)
Nizatidine
- Imprint:
-
MYLAN 5300
MYLAN 5300 - Strength:
- 300 mg
- Color:
- Purple
- Size:
- 17.00 mm
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-5300
- Inactive Ingredients:
- ammonium hydroxide
lactose anhydrous
silicon dioxide colloidal
D&C Red No. 28
FD&C Blue No. 1
FD&C Red No. 40
gelatin
isopropyl alcohol
magnesium stearate
butyl alcohol
pregelatinized starch
propylene glycol
sd-45 alcohol
shellac
silicon dioxide
simethicone
sodium lauryl sulfate
titanium dioxide
More resources
Nizatidine is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
